Mariner, LLC Novo Nordisk A S Transaction History

Mariner, LLC

$55.8 Billion
Q3 2024

A detailed history of Mariner, LLC transactions in Novo Nordisk A S stock. As of the latest transaction made, Mariner, LLC holds 346,679 shares of NVO stock, worth $37.5 Million. This represents 0.07% of its overall portfolio holdings.

Number of Shares

346,679

Previous 343,357 0.97%

Holding current value

$37.5 Million

Previous $49 Million 15.77%

% of portfolio

0.07%

Previous 0.1%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$119.07 - $145.42 $395,550 - $483,085	3,322 Added 0.97%	346,679 $41.3 Million
Q2 2024 Aug 13, 2024	BUY	$122.71 - $146.91 $3.56 Million - $4.26 Million	28,989 Added 9.22%	343,357 $49 Million
Q1 2024 May 15, 2024	BUY	$102.11 - $135.92 $1.76 Million - $2.34 Million	17,245 Added 5.8%	314,368 $40.4 Million
Q4 2023 Feb 14, 2024	BUY	$87.78 - $105.45 $1.32 Million - $1.58 Million	15,014 Added 5.32%	297,123 $30.7 Million
Q3 2023 Nov 13, 2023	BUY	$90.94 - $199.54 $14.1 Million - $30.8 Million	154,587 Added 121.22%	282,109 $25.7 Million
Q2 2023 Aug 11, 2023	SELL	$155.98 - $172.65 $290,122 - $321,129	-1,860 Reduced 1.44%	127,522 $20.6 Million
Q1 2023 May 12, 2023	SELL	$132.34 - $159.14 $788,614 - $948,315	-5,959 Reduced 4.4%	129,382 $20.6 Million
Q4 2022 Feb 14, 2023	BUY	$102.55 - $135.33 $339,030 - $447,400	3,306 Added 2.5%	135,341 $18.3 Million
Q3 2022 Nov 10, 2022	BUY	$95.28 - $116.93 $3.18 Million - $3.9 Million	33,325 Added 33.76%	132,035 $13.2 Million
Q2 2022 Aug 15, 2022	SELL	$103.24 - $121.81 $1.52 Million - $1.79 Million	-14,676 Reduced 12.94%	98,710 $11 Million
Q1 2022 May 13, 2022	BUY	$93.1 - $112.54 $286,003 - $345,722	3,072 Added 2.78%	113,386 $12.6 Million
Q4 2021 Feb 14, 2022	BUY	$95.88 - $117.08 $3.89 Million - $4.75 Million	40,563 Added 58.15%	110,314 $12.4 Million
Q3 2021 Nov 15, 2021	SELL	$84.42 - $106.62 $667,255 - $842,724	-7,904 Reduced 10.18%	69,751 $6.7 Million
Q2 2021 Aug 24, 2021	SELL	$67.66 - $84.76 $13,193 - $16,528	-195 Reduced 0.25%	77,655 $6.51 Million
Q1 2021 May 07, 2021	SELL	$67.06 - $75.82 $557,670 - $630,519	-8,316 Reduced 9.65%	77,850 $5.25 Million
Q4 2020 Feb 16, 2021	BUY	$63.89 - $73.8 $2.16 Million - $2.5 Million	33,863 Added 64.74%	86,166 $6.02 Million
Q3 2020 Nov 13, 2020	BUY	$63.69 - $70.22 $34,838 - $38,410	547 Added 1.06%	52,303 $3.63 Million
Q2 2020 Aug 14, 2020	BUY	$58.54 - $67.94 $548,988 - $637,141	9,378 Added 22.13%	51,756 $3.39 Million
Q1 2020 May 14, 2020	BUY	$49.46 - $64.78 $237,457 - $311,008	4,801 Added 12.78%	42,378 $2.55 Million
Q4 2019 Feb 13, 2020	BUY	$49.86 - $58.26 $44,674 - $52,200	896 Added 2.44%	37,577 $2.18 Million
Q3 2019 Nov 13, 2019	BUY	$47.54 - $53.43 $70,929 - $79,717	1,492 Added 4.24%	36,681 $1.9 Million
Q2 2019 Aug 14, 2019	BUY	$46.79 - $52.47 $66,488 - $74,559	1,421 Added 4.21%	35,189 $1.8 Million
Q1 2019 May 15, 2019	BUY	$46.36 - $52.63 $51,366 - $58,314	1,108 Added 3.39%	33,768 $1.77 Million
Q4 2018 Feb 13, 2019	BUY	$41.54 - $47.25 $138,826 - $157,909	3,342 Added 11.4%	32,660 $1.51 Million
Q3 2018 Nov 14, 2018	BUY	$46.76 - $51.24 $3,366 - $3,689	72 Added 0.25%	29,318 $1.38 Million
Q2 2018 Aug 14, 2018	BUY	$44.29 - $50.42 $520,230 - $592,233	11,746 Added 67.12%	29,246 $1.35 Million
Q1 2018 May 15, 2018	SELL	$48.49 - $58.14 $700,632 - $840,064	-14,449 Reduced 45.23%	17,500 $862,000
Q4 2017 Feb 09, 2018	SELL	$47.53 - $53.73 $31,274 - $35,354	-658 Reduced 2.02%	31,949 $1.71 Million
Q3 2017 Nov 14, 2017	BUY	$41.15 - $49.22 $1.34 Million - $1.6 Million	32,607	32,607 $1.57 Million

Others Institutions Holding NVO

# of Institutions

1,956

Shares Held

320M

Call Options Held

5.49M

Put Options Held

7.78M

View Full List

About NOVO NORDISK A S

Ticker NVO
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 2,257,289,984
Market Cap $244B
Description
Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...

More about NVO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Mariner, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Mariner, LLC with notifications on news.

Account